Use of thermobalancing therapy in ageing male with benign prostatic hyperplasia with a focus on etiology and pathophysiology

Allen, Simon; Aghajanyan, Ivan Gerasimovich

doi:10.1080/13685538.2016.1247151

Cited by 19 publications

(8 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The continuous heat exposure from thermoelement that does not exceed the normal body temperature has terminated micro-focus of hypothermia and spontaneous expansion of capillaries. The similar positive effect has been seen while clinical trial on TT in men with enlarged prostate (25). DATD removes the vicious cycle of spontaneous growth of capillaries, thereby relieving pressure in the prostate gland and the CP/CPPS symptoms (26).…”

Section: Discussionsupporting

confidence: 54%

New Independent Thermobalancing Treatment with Therapeutic Device for Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Allen

Aghajanyan

2017

Nephrourol Mon

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 54%

New Independent Thermobalancing Treatment with Therapeutic Device for Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Allen

Aghajanyan

2017

Nephrourol Mon

Self Cite

View full text Add to dashboard Cite

show abstract

“…Although TURP remains the gold standard for the surgical treatment of BPH, urologists and patients are seeking less invasive outpatient procedures to reduce the size of the prostate and alleviate LUTS (Allen & Aghajanyan, 2017). One of these treatments is transurethral bipolar radiofrequency treatment (Tempro © -Direx; Lim et al, 2012).…”

mentioning

confidence: 99%

Effect of bipolar radiofrequency thermotherapy on benign prostate hyperplasia

Diri

Gül

2019

Andrologia

View full text Add to dashboard Cite

| INTRODUC TI ONBenign prostatic hyperplasia (BPH) is the most common type of benign neoplasms in the male population. It affects approximately 50% and 90% men >60 and at around 85 years of age respectively (Lim, 2017). BPH can have a major effect on the quality of life because of symptoms, such as urinary urgency, frequency, nocturia, incomplete voiding of urine, weak urinary flow and hesitancy. The treatment options for BPH include conventional medications, such as alpha-1 blockers, 5-alpha reductase inhibitors and transurethral resection of the prostate (TURP; Foster et al., 2018). Although medical treatment slows the progression of BPH, approximately one in 10 patient expe-Abstract This study aims to evaluate the safety and efficacy of the new bipolar radiofrequency thermotherapy device (TEMPRO) in treating patients with benign prostate hyperplasia (BPH). Between December 2017 and November 2018, 72 male patients with BPH were included. All patients completed the International Prostate Symptom Score (IPSS) and International Index of Erectile Function-5 (IIEF-5) questionnaires. Physical examinations were performed, and prostate volume, prostatic urethral length andpost-voiding residual urine (PVR) were measured using ultrasound. Uroflowmetry was used to calculate the maximum flow rate of urination (Qmax). Bipolar radiofrequency thermotherapy was applied with TEMPRO system containing a 16Fr applicator. All patients were re-evaluated at 6 months post-operatively. The mean age of the patients was 63.22 ± 6.68 years. All patients were treated with local anaesthesia, and three patients were unable to complete the procedure. The median (IQR) visual analogue scale score was 1 (0-3) at 6 hr post-operatively. After 6 months, significant improvements were observed in the IPSS, QoL, Qmax and PVR values of the patients (p < .001 for Qmax, IPSS and QoL; p = .03 for PMR). The success rate of the procedure was similar between patients with prostate volumes <70 and >70 ml. Due to its low rate of complication, the TEMPRO © treatment is effective in treating BPH, especially among aged patients and those with serious symptoms. K E Y W O R D Sbenign prostate hyperplasia, radiofrequency, thermotherapy, treatment How to cite this article: Diri MA, Gul M. Effect of bipolar radiofrequency thermotherapy on benign prostate hyperplasia.

show abstract

“…TT with DATD by using continuous heat exposure that does not exceed the normal body temperature terminates the trigger of BPH development, the micro-focus of hypothermia, and the following spontaneous expansion of capillaries; stops and even reverses prostate enlargement. Thus, it was confirmed that the BPH cause related to the chain of changes at the microvascular level [33].…”

Section: Benign Prostatic Hyperplasiamentioning

confidence: 72%

Treatment of Kidney Stone Disease, Benign Prostatic Hyperplasia and Chronic Prostatitis with Thermobalancing Therapy should be listed in the Guidance for Health Professionals

2018

ARC Journal of Urology

View full text Add to dashboard Cite

The prevalence of kidney stone disease, chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) and benign prostatic hyperplasia (BPH) increases around the world. Long-term medications and surgical procedures for these non-life-threatening chronic conditions can develop serious side effects and complications. At the same time, Thermobalancing therapy (TT) with Dr Allen's therapeutic Device (DATD) has shown its high effectiveness in the treatment of chronic internal diseases. Discussion at many international conferences in 2017-2018 was aimed at treating various chronic non-malignant diseases with the help of Thermobalancing therapy, such as BPH, CP/CPPS, kidney stones and cardiovascular diseases. In the conferences were presented cases of TT with DATD of patients with kidney stone disease that confirm the ability of DATD to dissolve any type and size of kidney stone; discussed the outcomes from the clinical trials of TT in 124 men with BPH and 45 patients with CP/CPPS, before and after 6-month period they used DATD. The assured results of the cases and clinical trials reveal that TT with DATD treats the cause of kidney stone disease, CP/CPPS and BPH. Implementation of this therapy is needed today, as it helps patients avoid long-term drugs and surgical procedures, including extracorporeal shock wave lithotripsy (ESWL) with their risks and complications. In addition, it is a cost-effective solution. Therefore, conference participants proposed that TT with DATD should be included in the Guidance for health professionals.

show abstract

Use of thermobalancing therapy in ageing male with benign prostatic hyperplasia with a focus on etiology and pathophysiology

Cited by 19 publications

References 35 publications

New Independent Thermobalancing Treatment with Therapeutic Device for Chronic Prostatitis/Chronic Pelvic Pain Syndrome

New Independent Thermobalancing Treatment with Therapeutic Device for Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Effect of bipolar radiofrequency thermotherapy on benign prostate hyperplasia

Treatment of Kidney Stone Disease, Benign Prostatic Hyperplasia and Chronic Prostatitis with Thermobalancing Therapy should be listed in the Guidance for Health Professionals

Contact Info

Product

Resources

About